[go: up one dir, main page]

NO900251D0 - Fremgangsmaate for behandling eller hindring av intrinsik aldret hud med retinoider. - Google Patents

Fremgangsmaate for behandling eller hindring av intrinsik aldret hud med retinoider.

Info

Publication number
NO900251D0
NO900251D0 NO900251A NO900251A NO900251D0 NO 900251 D0 NO900251 D0 NO 900251D0 NO 900251 A NO900251 A NO 900251A NO 900251 A NO900251 A NO 900251A NO 900251 D0 NO900251 D0 NO 900251D0
Authority
NO
Norway
Prior art keywords
intrinsic
retinoids
prevention
procedure
treatment
Prior art date
Application number
NO900251A
Other languages
English (en)
Other versions
NO900251L (no
Inventor
Albert M Kligman
James A Mezick
Robert J Capetola
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25672393&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO900251(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CA000588835A external-priority patent/CA1335651C/en
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of NO900251D0 publication Critical patent/NO900251D0/no
Publication of NO900251L publication Critical patent/NO900251L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Physical Vapour Deposition (AREA)
  • Devices For Indicating Variable Information By Combining Individual Elements (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
NO90900251A 1989-01-19 1990-01-18 Fremgangsmaate for behandling eller hindring av intrinsik aldret hud med retinoider. NO900251L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29911989A 1989-01-19 1989-01-19
CA000588835A CA1335651C (en) 1989-01-20 1989-01-20 Method for the treatment or prevention of intrinsically aged skin with retinoids

Publications (2)

Publication Number Publication Date
NO900251D0 true NO900251D0 (no) 1990-01-18
NO900251L NO900251L (no) 1990-07-20

Family

ID=25672393

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90900251A NO900251L (no) 1989-01-19 1990-01-18 Fremgangsmaate for behandling eller hindring av intrinsik aldret hud med retinoider.

Country Status (15)

Country Link
EP (2) EP0815840A3 (no)
JP (1) JP2931349B2 (no)
AT (1) ATE164513T1 (no)
AU (1) AU636595B2 (no)
DE (1) DE69032182T2 (no)
DK (1) DK0379367T3 (no)
ES (1) ES2115590T3 (no)
FI (1) FI114968B (no)
GR (1) GR3026573T3 (no)
IL (1) IL93106A0 (no)
MY (1) MY106263A (no)
NO (1) NO900251L (no)
PH (1) PH27578A (no)
PT (1) PT92905B (no)
SG (1) SG73394A1 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051449A (en) * 1991-02-27 1991-09-24 Kligman Albert M Treatment of cellulite with retinoids
FR2674127B1 (fr) * 1991-03-20 1993-06-11 Oreal Composition cosmetique pour lutter contre le vieillissement de la peau contenant en association au moins un retinouide et au moins une dialkyl- ou trialkylxanthine.
DE69503368D1 (de) 1994-04-12 1998-08-13 Kao Corp Dermatologisches präparat
EP0814799A1 (en) * 1995-03-20 1998-01-07 Allergan Use of retinoids for the manufacture of a medicament for the treatment of restenosis
US5837224A (en) * 1996-01-19 1998-11-17 The Regents Of The University Of Michigan Method of inhibiting photoaging of skin
CN100360121C (zh) * 1997-02-25 2008-01-09 密执安州立大学董事会 防护和处理人皮肤经时性衰老的方法和组合物
AU744809B2 (en) * 1997-03-11 2002-03-07 Pola Chemical Industries Inc. Method for evaluating skin conditioning agents and process for producing external skin preparations
US6008254A (en) * 1997-05-09 1999-12-28 Kligman; Douglas E. Method of treating skin disorders with high-strength tretinoin
USH2043H1 (en) 1997-05-23 2002-08-06 The Procter & Gamble Company Skin care compositions
DE19806946A1 (de) * 1998-02-19 1999-09-09 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Retinoid sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen
DE19820392A1 (de) * 1998-05-07 1999-11-11 Beiersdorf Ag Wirkstoffkombinationen enthaltende Hautpflegemittel
FR2804323B1 (fr) * 2000-01-31 2006-07-07 Galderma Res & Dev Utilisation de composes de type retinoides en tant qu'agents anti-bacteriens
JP2002047125A (ja) * 2000-05-26 2002-02-12 Shiseido Co Ltd 皮脂分泌抑制用皮膚外用剤
JP2002284678A (ja) * 2001-03-23 2002-10-03 Ajinomoto Co Inc 皮膚外用剤
US20050202055A1 (en) 2004-03-11 2005-09-15 Koichi Shudo, Tokyo, Japan Anti-wrinkle agent
CN101431989B (zh) 2005-12-30 2011-11-23 雷文斯治疗公司 局部给药的精氨酸杂聚体
PT2056814E (pt) 2006-08-16 2014-08-25 Amderma Pharmaceuticals Llc Compostos de 2,5-di-hidroxibenzeno para o tratamento da psoríase
JP5665276B2 (ja) 2008-02-27 2015-02-04 花王株式会社 皮膚老化予防又は改善剤
EP2133066A1 (en) 2008-06-13 2009-12-16 Antonio Puig, S.A. Cosmetic and dermatological composition containing a mixture of retinol derivatives and tocotrienols.
WO2010072787A2 (en) 2008-12-22 2010-07-01 Johnson & Johnson Consumer France Sas A composition and method of treating skin conditions.
US11707442B2 (en) 2015-09-25 2023-07-25 The General Hospital Corporation Antibacterial and antifungal compounds
EA201891761A1 (ru) * 2016-02-03 2019-01-31 Галдерма Ресерч Энд Девелопмент Новые биароматические соединения пропинила, фармацевтические и косметические композиции, их содержащие, и их применение
CA3077331A1 (en) * 2017-09-28 2019-04-04 Johnson & Johnson Consumer Inc. Cosmetic compositions and method of treating the skin
GB2642547A (en) * 2024-07-12 2026-01-14 Univ Durham Compounds for use in senotherapy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1466062A (en) * 1974-04-09 1977-03-02 Knight K Cosmetic preparations
FR2479819A1 (fr) * 1980-04-04 1981-10-09 Fabre Sa Pierre Le retinoate de zinc, sa preparation et les compositions topiques le contenant
US4603146A (en) * 1984-05-16 1986-07-29 Kligman Albert M Methods for retarding the effects of aging of the skin
EP0224504B1 (en) * 1985-04-22 1992-03-18 Avon Products, Inc. Composition and method for reducing wrinkles
FR2591105B1 (fr) * 1985-12-11 1989-03-24 Moet Hennessy Rech Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide.
JP2606711B2 (ja) * 1986-07-16 1997-05-07 エム． クリグマン，アルバート 日光で損傷されたヒトの皮膚のレチノイドによる治療方法
ZA879063B (en) * 1986-12-22 1989-04-26 Hoffmann La Roche Use of 13-cis retinoic acid
FR2612775B1 (fr) * 1987-03-25 1991-10-11 Thorel Jean Compositions pour la prevention et le traitement de la degenerescence cutanee
EP0357646B1 (en) * 1987-04-06 1995-03-22 Daltex Medical Sciences, Inc. Treatment of aged skin with oral 13-cis-retinoic acid

Also Published As

Publication number Publication date
EP0815840A2 (en) 1998-01-07
FI114968B (fi) 2005-02-15
ATE164513T1 (de) 1998-04-15
JPH02288822A (ja) 1990-11-28
PH27578A (en) 1993-08-18
EP0815840A3 (en) 1998-03-04
GR3026573T3 (en) 1998-07-31
AU636595B2 (en) 1993-05-06
SG73394A1 (en) 2000-06-20
AU4857390A (en) 1990-07-26
PT92905A (pt) 1990-07-31
ES2115590T3 (es) 1998-07-01
DK0379367T3 (da) 1998-10-19
NO900251L (no) 1990-07-20
JP2931349B2 (ja) 1999-08-09
FI900293A0 (fi) 1990-01-18
EP0379367A2 (en) 1990-07-25
EP0379367B1 (en) 1998-04-01
DE69032182D1 (de) 1998-05-07
PT92905B (pt) 1995-12-29
EP0379367A3 (en) 1991-04-24
DE69032182T2 (de) 1998-08-20
IL93106A0 (en) 1990-11-05
MY106263A (en) 1995-04-29

Similar Documents

Publication Publication Date Title
NO900251D0 (no) Fremgangsmaate for behandling eller hindring av intrinsik aldret hud med retinoider.
HUT63053A (en) Process for producing pharmaceutical compositions comprising 9-cis-retinoic acid
AU4876190A (en) Compositions and method for the treatment of periodontal disease
CA2288706A1 (en) Use of high dose retinoids for the treatment of skin disorders
ATE89723T1 (de) Retinoide zur behandlung lichtgeschaedigter haut.
AU5471190A (en) Method of topically treating acne vulgaris
NO881051D0 (no) Metoder for behandling av solskadet, human hud med retinoider.
Orfanos et al. Laboratory investigations in patients with generalized psoriasis under oral retinoid treatment: a multicenter study of computerized data
FI904403A0 (fi) Fettsyrabehandling.
Thayer The effect of facial expression sequence upon judgments of emotion
IE873478L (en) Use of 13-cis retinoic acid
AU6255486A (en) Improvements in relation to drug treatments
KR950701520A (ko) 셀레노아미노산의 경피적용에 의한 외인성 피부노화의 재생법(Renewal of extrinsic aging of the skin by transdermal application of selenoamino acids))
DE69227072D1 (de) Pharmazeutische Zusammensetzung, die als Hilfsmittelbehandlung von Seborrhoid-Dermatitis, auch bei HIV-Patienten, verwendbar ist
ATE104544T1 (de) Synergistisches mittel zur hautdepigmentierung.
CA2033183A1 (en) Water-soluble vitamin a preparations for application to the skin
KR900011448A (ko) 레티노이드를 사용하여 자연적으로 노화된 피부를 치료 또는 예방하는 방법
Resnick Hospitalization and simple reaction time
ITMI922040A1 (it) Composizioni farmaceutiche per il trattamento di stati di iperaggregabilita' piastrinica
SE8500153D0 (sv) Nyckel for anvendning vid verdering av smertfornimmelser
UA12973A (uk) Спосіб лікуваhhя рожевих вугрів, ускладhеhих демодекозом